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Summary 
This report of the National Reference Laboratory (NRL) for residues of veterinary drugs in products of 
animal origin according to 96/23/EC described the activities employed in 2008.  
The communication with Routine Field Laboratories (RFL), the preparation of quality control samples 
for RFL and the advisory function for the competent authority and RFL are the main tasks of the NRL.  
 
Communication and advices 
In the period 2008 the NRL organized 5 official meetings with RFL (minutes are available) and 
several times informal meetings by telephone and e-mails. The competent authority was advised on 
national plan activities through the official 'Werkgroep National Plan' meetings. Furthermore the 
competent authority was advised on one specific issues viz. the draft SANCO document ‘Setting 
maximum levels for coccidiostats or histomonostats in food resulting from the unavoidable carry-over 
of these substances in non-target feed’. The NRL advised the Community Reference Laboratories 
(CRLs) regarding the method for validation of screening methods and validation of transferred 
screening methods. 
 
Coordinating activities 
The NRL prepared quality control samples (approximately 149 samples for 12 different analyses). The 
practical preparation of quality control samples is the aim of a separate project (project no.7203701). 
The NRL provided the RFL with 3 new methods of analysis and advised 5 times National Food 
control Laboratories outside the Netherlands - on their request - about different method of analysis for 
the determination of veterinary drugs. 
 
Participation in workshops and proficiency tests 
Employees of the NRL participated in workshops (3 times) and proficiency tests (3 times) organized 
by CRLs. NRL employees participated also in 8 proficiency tests organized by other organizations like 
FAPAS. The results of the proficiency tests were all acceptable (Z-score <2).  
RIKILT is accredited (according to ILAC G13:2000) for the organization of proficiency tests. In 2008 
one (international) proficiency test was organized by RIKILT. 
 
Finally, several scientific papers were written, posters presented and lectures given on trends in the 
analysis of veterinary drugs and growth promoting agents. For the coming period collaboration and 
communication of the NRL and RFLs will be continued. Special attention will be paid to the 
construction of multi-analyte method by combining existing method with minor differences. 
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1 Introduction 
The European Commission is committed to protecting consumers from intolerable health hazard, 
which may be associated with residues of veterinary drugs or even of non-licensed or forbidden 
substances in animal products intended for human consumption. For this purpose legislation on 
veterinary drug residue control has been established as the indispensable basis of the consumer 
protection within the EU. The European residue legislation commits the Member States to establish a 
national residue control plan and provides for the establishment of a hierarchically structured system 
of Community Reference Laboratories (CRLs), National Reference Laboratory (NRLs) and Routine 
Field Laboratories (RFLs).  
The responsibilities of the NRL are described in 96/23/EC and included the following items: 
- coordinating the work of the other NRLs responsible for residue analysis, in particular by 
coordinating the standards and methods of analysis for each residue or residue group concerned, 
- assisting the competent authority in organizing the plan for monitoring residues, 
- periodically organizing comparative tests for each residue or reside group assigned to them, 
- ensuring that national laboratories observe the limits laid down, 
- disseminating information supplied by the CRLs, 
- ensuring that their staff members are able to take part in further training courses organized by the 
Commission or by CRLs. 
  
This report described the activities of the NRL for veterinary drugs according to EU document 96/23/ 
EU. It covers the groups of compounds assigned to RIKILT-NRL regarding veterinary health viz. 
nitrofurans, dapson, nitroimidazoles, chloroform, antibiotics (including sulphonamides, quinolones, 
tetracyclines), anthelmintics, coccidiostats and non-steroidal antiinflammatory drugs (NSAIDs). These 
groups belong to Group A6, Group B1, B2 (a, b, e) compounds as described in EU document 
96/23/EC.  
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2 Communications and advices 
One of the tasks of the NRL is to communicate with the Competent Authority, RFLs and other NRL 
on issues regarding the control of residues of veterinary drugs. Sometimes the communication is on a 
regular base and sometimes ad hoc. The same is applicable to the advices given by the NRL. 
Sometimes advice is requested and sometimes advice is given. The communication and advice 
activities employed by the NRL in 2008 are described below.  
2.1 Communications  
2.1.1 With competent authority 
On a regular base there is meeting between the competent authority The Ministry of Agriculture, 
Nature and Food Quality on the content of the National Monitoring Plans.  
In 2008 RIKILT participated in the working group setting up the plan for monitoring residues. 
 
During 2008 there were 3 meetings of this working group. 
2.1.2 With Routine Field Laboratory (Food and Consumer Product Safety Authority, 
Laboratory Region East) 
On a regular base the management of RIKILT communicate with the management of the Food and 
Consumer Product Safety Authority, Laboratory Region East  (in this report referred to as VWA-East). 
On a regular base the analytical technicians of RIKILT communicate with the technicians of VWA-
East. See also item 3.1.  
 
The NRL had three official management meetings with RFL and five technical meetings (minutes are 
available) and several times unofficial meetings by telephone and e-mails. 
2.1.3 With National Reference Laboratory 
On a regular base the management of the NRLs in the field of veterinary health viz. RIVM and 
RIKILT meets with the management of VWA-East in the so called R3 meeting. During these meetings 
the analytical activities are discussed and there is an exchange of information and experiences. 
Furthermore within the R3 meeting the requests for proficiency tests are being discussed and 
proficiency tests planned. Next to the R3 meetings on a regular bases the activities in the field of 
veterinary drugs analysis regarding the technical innovations and trends are discussed in the Q3 
(Quality-assurance, Quality-control, Quartet) meeting. In the Q3 group participate the R3 laboratories 
and TNO-Ducares.  
 
In 2008 the R3 group had no formal meeting. There were two informal meeting during the Euro 
Residue VI conference in Egmond aan Zee (May 2008). 
 RIKILT Report 2009.006 9
- There was communication by e-mail and telephone to discuss and combine the comments on the 
draft CRL document (version 4) regarding the proposed method for the 'Validation of screenings 
methods' and the 'Validation of transferred screening method'. See also item 2.2.1. 
- There was communication by e-mail and telephone between RIKILT and RFL (parties involved in 
coccidiostats analysis) to discuss the draft SANCO document 3417/2008 ‘Setting maximum levels for 
coccidiostats or histomonostats in food resulting from the unavoidable carry-over of these substances 
in non-target feed’.  See also item 2.2.2. 
 
In 2008 the Q3 group had no official meeting. There were two informal meeting during the Euro 
Residue VI conference in Egmond aan Zee (May 2008). 
2.2 Advices 
2.2.1 To directors of the CRL's  regarding validation of screening method 
Two CRL documents describe guidelines for the validation of screeningmethods and the validation of 
transferred screening method. The following documents were for discussion: 
1) Guide for analytical validation of screening methods (Draft 4 Validation_screening-September 
2007) by Valerie Gaudin en Pascal Sanders from CRL-Fougeres and Petra Gowik and Steffen Uhlig 
form CRL-Berlin. 
2)  Guideline for validation of transferred screening methods; Non-Paper 23/6/08 (CRL-Fougeres and 
CRL-Berlin). 
 
The NRL's were asked for their comments on these documents.  
 
RIKILT gave their opinion on the documents and asked for input from RIVM and RFL.  
The final comments (proposed by RIKILT and evaluated by RIVM and RFL) were sent by RIKILT to 
the directors of the CRLs. See Annex 1. 
2.2.2 To competent authority regarding draft SANCO documents 
RIKILT was asked by the competent authority to give their opinion about the draft SANCO document 
3417/2008 ‘Setting maximum levels for coccidiostats or histomonostats in food resulting from the 
unavoidable carry-over of these substances in non-target feed’. Final comments were sent by the NRL 
to the competent authority (by e-mail as requested). See Annex II. 
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3 Coordinating activities  
3.1 Preparation of quality control samples 
The activities employed for the RFL regarding the preparation of quality control samples are described 
in a separate project (WOT programme on Food Safety - Part 3 Veterinary Drugs; project 7203701 
Analytical Chemical Quality Control project for Laboratory VWA-East). In 2008 approximately 149 
quality control samples for 12 different analyses were prepared. The details regarding the prepared 
samples, the analytical results obtained and the discussion/meetings between VWA-East and RIKILT 
are described in RIKILT Annual report 2008 'De Chemische Borging van Laboratorium VWA door 
RIKILT ' by B.J.A. Berendsen, status : in preparation.  
 
3.2 Providing analytical methods 
On request RIKILT will provide the RFLs with methods of analysis and reference materials. Primary 
this responsibility is focused on the Dutch laboratory (VWA-East), however within the framework of 
collaboration information has been shared with laboratories in Belgium, UK and Germany also. 
 
In 2008 the following methods have been provided to VWA-East: 
LC-MS/MS-analysis of Triclabendazol (and metabolites) (RSV A0865); 
LC-MS/MS-analysis of Benzimidazoles en triclabendazol in animal tissue (revision of RSV A0768) 
LC-MS/MS-analysis of NSAID’s (revision of RSV A0702) 
LC-MS/MS-analysis of antiviral drugs (draft RSV A1085) 
 
The method for the analysis of quinolones in fish and meat (RSV 0900) and the method for the 
analysis of coccidiostats in eggs (RSV A1067) were - on their request - also provided to VWA-East. 
 
The RFL (VWA-East) observed problems with the analysis of aminoglycosides and after several 
meetings and training of personnel by the NRL the VWA-East was able to perform the method at their 
own lab. 
 
Futhermore methylated internal standards for the analysis of  aminoglycosides were provided to the 
VWA-East. 
 
 
Next to the national RFLs several national food laboratories from other countries were asking for 
trainings and advices. 
- Training on the analysis of carbadox and olaquindox analysis was given to  Zina Theodorou from 
NRL Cyprus. 
- Advices on the analysis of antibiotcs were given to Ms. Enktuya National Food Laboratory in 
Mongolia. 
- Information regarding the set up of National Monitoring Plans for residue analysis within the EU was 
exchanged with Dr. Thomas Korth, manager Residue Chemistry and Laboratory Performance 
Evaluation from the National Food Laboratory in Canberra (Australie). 
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- Indonesian delegates visited RIKILT for a training. They were informed about: Setting up National 
Monitoring Plans for Fish and Fish products; Analysis of Antibiotics and CRL/NRL network in the 
EU. 
- Dr. Hibaru Mandiri (Mutucertification; Indonesia) visited RIKILT and was informed about the 
accreditation/certification of analytic methods. 
- Zahira Herrera from Food Laboratory in Brasil worked as a visiting scientist on methods for 
antibiotic screening of food. 
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4 Analytical activities 
The activities employed for the RFL regarding the development of analytical methods to be used in for 
example the National Monitoring Program residues are described in a separate project (WOT 
programme on Food Safety - Part 3 Veterinary Drugs; project 7152101 Development of methods of 
analysis for the benefit of the execution of the National Plan according to guideline 96/23/EC). The 
details regarding the deliverables are described in the annual report of the WOT programme on Food 
Safety.  
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5 Participating in CRL workshops  
In 2008 employees of RIKILT participated to the following workshops: 
 
- CRL-Workshop Technical, Analytical and Statistical Issues, June 3-6, BVL Berlin. 
T. Zuidema actively contributed to this workshop by means of an oral presentation "The 
implementation of SPE-LC-MS/MS for veterinary drugs".  
 
- CRL-Workshop antibiotics: Strategies of Confirmation Methods and Proficiency Testing, June 26-27 
2008, AFSSA Fougeres.  
R. Peters  actively contributed to this workshop by means of an oral presentation about the 
organisation of proficiency testing by RIKILT. 
 
- CRL-workshop hormones, 22-24 October 2008, RIVM, Bilthoven. R. Peters actively contributed to 
this workshop by means of an oral presentation about ToF-MS for multi-analyte screening of 
veterinary drugs and growth promoting agents. Furthermore J. Lasaroms was an observer in this 
workshop. 
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6 Participating in proficiency tests 
Due to the scope of the NRL task assigned, RIKILT participated in proficiency tests organized by the 
CRLs, FAPAS and other international organizations: 
In 2008: 
Malachitegreen in fish (FAPAS); z-score 0.3 
Tetracyclines in meat (FAPAS); z-score 0.4 
Anthelmintica in milk (BVL); not yet reported 
Nitroimidazoles in meat (IRMM) used as an quality control sample; good results 
Chloroamfenicol in shrimps (FAPAS); z-score 1.2 
Nitrofuranes in meat (AFASSA); not yet reported 
Tetracylines en sulfonamides in meat (Progetto Trieste)  
Chloroamfenicol in meat (Progetto Trieste); z-score -0.16 
Robenidine in animal food (KDLL); no z-score due to limited number of participants n=4  
Quinolones in meat (FAPAS); z-score 0 
Chloroamfenicol in urine (RIVM); not yet reported 
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7 Posters, publications and presentations 
7.1 Posters 
Poster presented at the Euro Residue VI Conference on Residues of Veterinary Drugs in Food; 
Egmond aan Zee; 19-21 May, 2008. Page numbers refer to the proceedings of the Euro Residue 
Conference (see 7.2). 
 
CAMPARISON OF THREE MICROBIAL SCREENING METHDODS FOR ANTIBIOTIC 
SCREENING OF ROUTINE MONITORING SAMPLES 
Mariël G. Pikkemaat, Sabrina Oostra-van Dijk, J. W. Alexander Elferink, Michel Rapallini 
419-423 
 
FLOW CYTOMETRIC IMMUNOASSAY FOR SULFONAMIDES IN 
MILK, BLOOD SERUM, MEAT DRIP AND EGGS. 
Monique E. Bienenmann-Ploum, Wouter de Keizer, Henriëtte D.L.M. van Eekelen, Aldert 
A. Bergwerff, Willem Haasnoot and Michel W.F. Nielen. 
425-430 
 
PERFORMANCE EVALUATION OF HORMONE AND VETERINARY 
DRUG RESIDUE SCREENING BY ULTRA PERFORMANCE 
CHROMATOGRAPHY COUPLED TO TIME-OF-FLIGHT AND 
ORBITRAP MASS SPECTROMETRY 
Ed van der Heeft, Paul Zomer, Linda A.M. Stolker and Michel W.F. Nielen 
565-569 
 
PROFICIENCY TESTING IN THE FIELD OF VETERINARY DRUGS 
IN FOOD 
Bjorn J.A. Berendsen, Linda (A).A.M. Stolker, Hans (J).A. van Rhijn 
699-704 
 
THE IMPROVEMENT OF SAMPLE THROUGHPUT IN RESIDUE 
ANALYSIS USING THE 96-WELL FORMAT 
Bjorn J.A. Berendsen, Linda (A).A.M. Stolker, Hans (J).A. van Rhijn 
705-710 
 
COMPREHENSIVE SCREENING OF VETERINARY DRUGS 
IN FOOD USING UPLC COMBINED WITH FULL SCAN MS 
DETECTION 
Linda Stolker, Efraim Oosterink, Paula Rutgers, Johan Lasaroms, Ruud Peters, Hans 
Mol, Hans van Rhijn, Michel Nielen 717-722 
 
MULTIRESIDUE METHOD FOR THE SIMULTANEOUS 
DETERMINATION OF BENZIMIDAZOLES IN BOVINE MILK BY 
ON-LINE SPE-LC-MS/MS 
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Frédérique L. van Holthoon and Tina Zuidema 
849-854 
 
FORMATION OF SEMICARBAZIDE FROM AZODICARBONAMIDE 
AND BIUREA DURING BREAD PREPARATION: A MODEL STUDY 
Patrick P.J. Mulder, Elodie Mothiron1, Hans (J).A van Rhijn 
1043-1047 
7.2 Publications in proceedings of Euro Residue 
All presented papers (posters and oral) of the Euro Residue VI Conference on Residues of Veterinary 
Drugs in Food; Egmond aan Zee; 19-21 May, 2008; are published in the proceedings of the 
Conference. 
Residues of Veterinary Drugs in Food Edited by: LA. Van Ginkel and A.A. Bergwerff; ISBN 978-90-
804925-3-0. 
7.3 Other publications 
The following article was published in a peer reviewed journal: 
Title: Comprehensive screening and quantification of veterinary drugs in milk using UPLC–ToF-MS 
Authors: A. A. M. Stolker & P. Rutgers & E. Oosterink & J. J. P. Lasaroms & R. J. B. Peters & J. A. 
van Rhijn & M. W. F. Nielen 
Source: Anal Bioanal Chem (2008) 391:2309–2322. 
 
Title: A generic method for the quantitative analysis of aminoglycosides (and spectinomycin) in 
animal tissue using methylated internal standards and liquid chromatography tandem mass 
spectrometry 
Authors: F.L. van Holthoon, M.L. Essers, P.P.J. Mulder, S.L. Stead, M. Caldow, H.M. Ashwin, M. 
Sharman,  
Source: Anal. Chim. Acta, In Press, Accepted Manuscript. 
 
Regarding the use of Time-Of-Flight- MS analysis of veterinary drugs a Chapter for a ACS-issue on 
ToF-MS was submitted.  
Author: A.A.M. Stolker;  
Title: Application of (UP)LC-ToF-MS for residue analysis of veterinary drugs and growth promoting 
agents in products of animal origin. 
Status: The book is in press. Book is edited by Imma Ferrer. 
7.4 Presentations 
Oral presentations presented at the Euro Residue VI Conference on Residues of Veterinary Drugs in 
Food; Egmond aan Zee; 19-21 May, 2008: 
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HERBAL ALTERNATIVES FOR ANTIMICROBIAL GROWTH 
PROMOTERS 
Maria J. Groot, Tedje van Asseldonk, Johanna Fink, Bart Halkes4 and Gerdien Kleijer- 
Ligtenberg 53-58 
 
TRENDS IN MONITORING THE USE OF VETERINARY DRUGS 
AND GROWTH-PROMOTING AGENTS 
Linda Stolker, Marco Blokland, Tina Zuidema, Paul Zoontjes, Saskia Sterk, Michel 
Nielen, Leen van Ginkel 81-86 
 
- In August 2008 an Indonesian delegation was visiting the Netherlands. The delegation were 
interested in the NRL/CRL organization structure. The delegation visited RIKILT and A.A.M. Stolker 
gave a presentation regarding ‘Official control of residues of veterinary drugs in food’. 
- In November 2008 during the WOT Theme 3 Symposium Organized by LNV in Den Haag,  a 
presentation was given regarding the NRL-project. Hand-outs of this presented are presented in Annex 
III. 
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8 Other NRL activities 
8.1 Organisation of proficiency tests 
In 2006 RIKILT has obtained accreditation for organizing proficiency tests focusing on veterinary 
drugs.  
The following proficiency tests were organized by RIKILT: 
- The analysis of residues of macrolides in meat. Results of this proficiency study are described in 
RIKILT report 2009.003 of  February 2009 'Proficiency study for macrolides in meat' by B.J.A. 
Berendsen. The summary is presented in Annex IV. 
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9 Plan for NRL activities 2009 
The quality assurance program for the RFL will be continued as well as the regular meetings between 
the NRL, RFL and the NRLs within the Netherlands (technical meetings and R3 meeting).  
Furthermore the employees of the NRL will participate in the workshops organized by the CRLs and 
in the organized proficiency tests (for the relevant groups of compounds). 
Special attention will be paid to harmonization of analytical methods for the analysis of veterinary 
drugs in products of animal origin. Nowadays many LC-MS/MS based methods are available for the 
analysis. Some of them only differs by the composition of the LC mobile phase or by the LC column 
used or by the SPE material used for the extraction It is worthwhile to find out it is possible to use one 
'standard LC-MS/MS' for the analysis of different classes of veterinary drugs. Due to the fact that most 
of the analytical methods are fully validated and accredited some minor changes in the LC-MS/MS 
systems do have influence on the accreditation status. Therefore, a short additional validation 
procedure has to be developed which can by applied in case an accredited analytical method is slightly 
changed.  
The advance will be that less analytical method will be used which simplifies the control of veterinary 
drugs in products of animal origin.  
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Annex I    Comments on CRL proposed guidelines for validation 
of (transferred) screening methods 
From: Stolker, Linda 
Sent: woensdag 1 oktober 2008 11:05 
To: 'v.gaudin@fougeres.afssa.fr'; 'Dr. Petra Gowik'; 'Leen van Ginkel' 
Cc: Peters, Ruud (RIKILT) 
Subject: comments on guide for validation of screening methods 
 
Attachments: Comments on screening guidelines.doc 
Dear colleagues, 
  
As a follow up of the CRL-workshops in Berlin and Fougeres hereby the requested comments on the 
guidelines for validation.  
From our own experiences with method validation it is concluded that each validation study has its 
own specific problems, due to analytes (metabolites are included) technique used (microbiology 
chemical/physical) number of analytes to be detected, number of matrices included etc. One additional 
(to the attachment) remark is that we think that it is very important that the CRL's advise the 
NRL/RFL in case they observe any problems or have any questions regarding the set up of the 
validation study.  
  
In case you have any additional question regarding our comments on the guidelines please do not 
hesitate to contact me, 
  
Kind regards 
  
Linda Stolker 
  
Dr. A.A.M. Stolker 
Analysis and Research/Veterinary drugs 
RIKILT-Institute of food Safety 
P.O. Box 230 
6700 AE Wageningen 
Tel: +31 (0) 317 480390 
  
 
1. Guide for Analytical Validation of Screening Methods 
Draft document, version 4 
 
The EC Decision 2002/657/EC defines screening methods as: “methods used to detect the presence of 
a substance or class of substances at the level of interest. Such methods allow for high-throughput 
screening to identify potential non-compliant samples. They are specifically designed to avoid false 
compliant results”. For a few years now there is some debate whether, and how, screening methods 
should be validated. At the NRL workshop of June, 25-27 in Fougeres, France, the latest draft of the 
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document “Guideline for Analytical Validation of Screening Methods, draft 4, September 2007” was 
presented. In this document guidelines for the validation of biological, biochemical and physico-
chemical methods, qualitative as well as quantitative are given. 
 
In our opinion this guideline, although it is a draft 4 version, still appears fairly complicated and seems 
unable to really choose between qualitative and quantitative methods. In the end the document 
distinguishes between 6 procedures; biological, biochemical and physico-chemical, both qualitative as 
well as quantitative. However, we think that it should be possible to have no more than two 
procedures, one for qualitative and one for quantitative methods, without further differentiation. In 
addition we notice that the recommended number of samples in some cases is very high and that up to 
four concentration levels are used, even for qualitative methods. In this way especially the validation 
of qualitative screening methods becomes as complicated, and time and money consuming, as a 
quantitative confirmation method. For that reason, and a broader acceptance by users, we propose a 
more straightforward guideline for validation that gives a strategy for a qualitative and a quantitative 
screening. With regard to the strategy we suggest the following approach:      
 
Qualitative methods give a simple “yes” or “no” answer whether this is by a chromatographic peak 
(physiochemical methods), a color reaction (biochemical methods) or an inhibition zone (biological 
methods). To differentiate between compliant and non-compliant samples a “matrix-matched control 
point” can be employed. Such a control point may be considered as a cutoff concentration at some 
percentage below “The level of Interest”. The level of interest is usually either the Regulatory Limit 
(MRL, MRPL) or an “Action Level/Limit”. We consider such a methodology particularly useful when 
screening large batches of samples which are likely to be compliant. False negative results are of the 
greatest concern in screening procedures since suspected samples are subsequently checked using a 
confirmation method. By setting the “matrix-matched control point” at 50% of the level of interest, 
methods generally produce less than 5% false negatives. During validation this can be confirmed by 
analyzing 20 samples spiked at the level of this “control point”. Only if the sensitivity of the method is 
such that the “matrix matched control point” is close to the level of interest, a higher number of 
samples may be required to demonstrate less than 5% false negatives. The false positive ratio can be 
determined in the same manner by analyzing 20 blank samples.  
 
As an example of this approach we included table 1 that contains data from a validation of a screening 
method for veterinary drugs in milk where 28 spiked samples were analyzed over 4 different days. By 
using a matrix matched control point at 50% of the level of interest, the false negative rates were 
below 5% for all substances with the exception of phenylbutazone. The latter probably results from the 
poor sensitivity of this substance in this method. As expected the false negative rate increases when 
the matrix matched control point is chosen at 75% of the level of interest, especially for compounds 
with a poor sensitivity such chlorotetracycline and phenylbutazone. Therefore, the “safe” level for the 
matrix matched control point will depend on the sensitivity and with a poor sensitivity more control 
sample should be analyzed. In addition, if the level of interest is set much lower than the MRL, fewer 
replicates will be needed during validation where we consider 20 as a minimum.             
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Table 1. False negative rates with a matrix matched control point at 50% and 75% of the
level of interest
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Benzimidazoles
albendazole 100 50 0 (28) 0 (28)
fenbendazole 10 10 0 (28) 0 (28)
flubendazole - 2 0 (28) 1 (28)
oxfenbendazole 10 10 0 (28) 0 (28)
Macrolides
erythromycine 40 40 0 (28) 0 (28)
josamycin - 50 0 (28) 0 (28)
spiramycine 200 50 0 (28) 0 (28)
tylosin 50 50 0 (28) 0 (28)
Quinolones
difloxacin - 2 0 (28) 3 (28)
flumequine 50 50 0 (28) 2 (28)
nalidixic acid - 2 0 (28) 0 (28)
norfloxacin - 25 0 (28) 0 (28)
oxolinic acid - 2 0 (28) 1 (28)
Sulphonamides
dapsone 5 5 0 (28) 2 (28)
sulphadiazine 100 50 0 (28) 0 (28)
sulphadimethoxine 100 50 0 (28) 0 (28)
sulphadoxine 100 50 0 (28) 0 (28)
Tetracyclines
chlorotetracycline 100 100 0 (28) 11 (28)*
doxycycline - 100 0 (28) 0 (28)
oxytetracycline 100 100 0 (28) 1 (28)
tetracycline 100 100 0 (28) 2 (28)
NSAIDs
diclofenac 5 50 0 (28) 0 (28)
fenbufen - 50 0 (28) 1 (28)
ketoprofen - 50 0 (28) 0 (28)
mefanamic acid 10 50 0 (28) 4 (28)
phenylbutazone 5 50 3 (28)* 10 (28)*
piroxycam - 50 0 (28) 0 (28)
propyphenazone - 50 0 (28) 0 (28)
*; The screening method had a low sensitivity for these substances
No. of false negatives
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A quantitative method, also a quantitative screening method, is expected to produce an accurate 
concentration. In our opinion this means that with respect to dynamic range, accuracy and precision, 
such a method meets the same requirements as a true quantitative confirmatory test, e.g. 2002/657/EC 
can be followed. 
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2. Guideline for validation of transferred screening methods 
 
For the procedure necessary to show that a method is “fit for purpose”, the procedure above (item 1) 
can be used. However by transfer of method not all the analyte-matrix combinations have to be tested 
but only the most critical (lowest sensitivity, most polar, most non-polar, etc).  
More important is that during sample analysis for each series of samples at least 2 additional blank and 
2 additional ‘positive samples’ are analyzed.  
After ten series the data of the 20 blank and 20 control samples has to be evaluated for containing false 
non-compliant and false compliant results. These sets of blank and positive samples should preferably 
consists of a broad range of matrix-analyte combination, representative for the scope of the method. 
 
 
Ruud Peters, Linda Stolker 
RIKILT – Institute  of Food Safety 
Wageningen 
The Netherlands 
Date: 30 September 2008 
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Annex II    Comments on draft document SANCO 0324/2008 
From: Stolker, Linda 
Sent: maandag 17 november 2008 12:04 
To: hans.van.rhijn@vwa.nl 
Cc: Zuidema, Tina 
Subject: comments on draft EU regulation regarding food 
 
Comments on SANCO document 3024/2008  
Setting maximum levels for coccidiostats or histomonostats in food resulting from the unavoidable 
carry-over of these substances in non-target feed 
 
 
First of all it is good to mention that is an advantage that there is some of a regulation concerning the 
contamination of food by the unavoidable carry over of histomonostats and coccidiostats during feed 
production. 
 
However I do have some remarks 
The under laying study of EFSA concerning the maximum levels of the compounds in food after 
administration of contaminated (by unavoidable carry over of histomonostats and coccidiostats) is an 
alternative approach for setting limits. It differs from the approaches used for setting MRPLs and 
MRLs. Is it desirable to introduce a third approach? The final proposed Maximum Levels in food are 
for some of the compounds (due to the used approach) relatively low. I mean by this the levels are 
relatively low in comparison with some of the existing MRLs for target animal species.  
From the analytical part of view it is probably possible to detect the low proposed maximum limits 
however for some compounds e.g. semduramycin, maduramycin, lasalocid (eggs) and narasin (eggs 
milk) it will be rather difficult to obtain the proposed low limits. Therefore it is necessary to optimize 
existing methods and/or develop new methods to finally reach the low detection limits (<5 µg/kg) 
necessary for monitoring purposes.  
 
It is worthwhile to think about the option to set the limits not lower than10 µg/kg unless: 
- The limit of 10 µg/kg is not a safe limit (based on the toxicological studies) 
- There is a MRL for a target species which is below 10 µg/kg. 
When the maximum limits are set at 10 µg/kg there is a possibility to use a multi-analyte methods for 
monitoring purposes. In this way the new limits can probably more easily be included in already 
developed and validated methods for coccidiostats or histomonostats in target species. 
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Annex III    Hand-out presentation Symposium on WOT Theme 3 
(Den Haag, November 2009) 
Kwaliteit onder controle ?
Linda Stolker, Bjorn Berendsen
 
Wat is kwaliteit?
Product of dienst is van goede
kwaliteit indien: 
? Het voldoet aan de wensen
van de klant
? Het voldoet aan
onafhankelijk vastgestelde
criteria (normen; richtlijnen)
Verwacht Geleverd
Afspraak
Duidelijk Betrouwbaar
Tevreden
 
Wensen van de klant
? Wie is de klant?
? EU ? LNV
? Wat vraagt de klant en 
waarom?
? Uitvoer van WOT 
Voedselveiligheid
• Thema 3 
Dierbehandelingsmiddelen
– NRL/QA/QC
EU wetgeving
? Richtlijn
? 96/23/EC (96/22/EC; 
2003/74/EC)
? Beschikking 2002/657/EC
? Verordening EEC 2377/90
? Verordening EC 882/2004
 
Afstemming van activiteiten
? Nationaal Referentie
Laboratorium
? Borging VWA Lab
? Microbiologisch
? Histologisch
? Analytisch-chemisch
? Validatie & accreditatie methoden
dierbehandelingsmiddelen
EU wetgeving
? Richtlijn 96/23/EC 
? Beschikking 2002/657/EC
RIKILT-projecten binnen
WOT Thema 3: NRL/QA/QC
 
Afstemming activiteiten
Overlegstructuur LNV RIKILT
? Werkgroep Nationaal Plan
? Aantal en aard van de monster
? Te meten dierbehandelingsmiddelen
? NP wordt opgesteld en geëvalueerd
 
Afstemming activiteiten; overlegstruktuur
? CRL/NRL/RFL
? RIKILT-RIVM-VWA (voorheen CLRVV) vormen R3 
overleg; regelmatig overleg
• Uitwisseling van ervaringen op technisch gebied
• Bespreken van knelpunten; methoden, standaarden
• Afstemming ringtesten
? RIKILT-RIVM-VWA-TNO/Ducares vormen Q3 (Quality-
accurance, Quality control, Quartet) overleg; ad hoc 
• Uitwisseling van ervaringen op technisch gebied
? RIKILT-VWA 
• Managementniveau
• Technisch inhoudelijk niveau
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Toetsen aan criteria
? Voor laboratorium: ISO 17025
? Gebruikte methode: 2002/657/EC
? Borging van de kwaliteit in de 
praktijk
? Referentie standaarden
? Analyse van borgingsmonsters
? Deelnemen aan ringtesten
Methoden
Lab
Monsteranalyse
 
ISO 17025
Onafhankelijke beoordeling door de Raad voor Accreditatie
(RvA) 
? Laboratorium organisatiestructuur
? Laboratorium manangement
? Kwalificatie mensen
? Status apparatuur
? Algemene kwaliteitsborgingssysteem
? Klachtenprocedures
? Rapportages
? Monsterregistratie
? ARBO……
lab
 
2002/657/EC Validatiecriteria
FVO inspecties
? Specifiek voor het onderzoek uitgevoerd onder
richtlijn 96/23/EU
? Bevestigings criteria
? Validatie criteria
methoden
 
Borging van de kwaliteit in de praktijk
? NRL antibiotica zorgt voor borging van RFL door 
? aanleveren van methoden
? aanleveren van referentiestandaarden
? doorgeven van via CRL ontvangen informatie
? bereiding van borgingsmonsters
? organiseren van ringtesten
monsteranalyse
 
Aanleveren gevalideerde methoden*
? Nitroimidazoles in plasma
? Stanozolol in plasma
? Aminoglycosiden in vlees
? Salmeterol in haar
? Steroidhormonen in 
pluimveelever
? Coccidiostatica in eieren
? Macroliden in vlees
? Steroidglucuroniden in urine
? Carbadox en olaquindox in vlees
? …………………
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*ook voor uitvoering van AID onderzoek
 
Aanleveren van standaarden
? Gezamenlijke aankoop van dure gedeutereerde
interne standaarden
? Nieuwe referentie standaarden die moeilijk
commercieel verkrijgbaar zijn
monsteranalyse
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Aanleveren van informatie
NRL informeert RFL 
? Informatie van CRL’s (AFSSA-Fougères, RIVM-
Bilthoven, BVL-Berlijn)
? Veranderende regelgeving
? Validatiecriteria…
monsteranalyse
 
Borgingsmonsters
-Bereiding materiaal
-Meten van concentratie
RIKILT/NRL
Bepaalt de 
concentratie
VWA/RFL
x
x
RIKILT-VWA: Evaluatie van de resultaten
Optimalisatie/harmonisatie van 
methoden
100±20 µg/kg
80-120 µg/kg
<80 µg/kg 
>120 µg/kg
antibioticum
 
Bereiding van borgingsmonsters
? Bereiding van borgingsmonsters
? RIKILT en VWA bepalen in overleg type 
borgingsmateriaal
 
Bereiding borgingsmonsters
? Quinolonen in pluimveevlees
? Dapson in varkensvlees
? Nitroïmidazolen in varkensvlees
? Quinolonen in ei
? Avermectines in varkenslever
? Levamisol / thiabendazol in varkenslever
? Sulfonamiden in varkensvlees
? Nitrofuranen in pluimveevlees
? Coccidiostatica in pluimveevlees
? Tetracyclines in pluimveevlees
? Desoxycarbadox in varkensnier
 
 
Resultaten
monsteranalyse
 
Organiseren van ringtesten
Georganiseerde ringtesten:
? Quinolonen in pluimveevlees (2006)
? Penicillines in varkensvlees (2007)
? Quinolonen in ei (2007/2008)
? Macroliden in vlees en nier (2008)
RIKILT is geaccrediteerd voor het organiseren van ringtesten
(Voglens ILAC/G13 ; ISO/IEC 43-1 en 43-2)
monsteranalyse
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Quinolonen in ei
 
Voorbeeld evaluatie ringtest resultaten
Z-scores van 15 laboratoria
Bepaling van enrofloxacine in ei (48 µg/kg)
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-2.0
-1.5
-1.0
-0.5
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0.5
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3 13 8 15 18 11 12 16 2 17 7 9 5 4 6
Lab code
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Conclusie Kwaliteit onder controle !
Verwacht Geleverd
Afspraak
Duidelijk Betrouwbaar
Tevreden
 
© Wageningen UR
Dank voor uw aandacht
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Annex IV    Summary report 2009.003: Inter-Laboratory study 
for macrolides in meat 
Thirteen laboratories subscribed for participation in the proficiency study macrolides in porcine tissue. 
Eleven laboratories managed to submit results for muscle. Ten of them were also able to report results 
for the kidney samples. Seven of the laboratories that reported results applied a validated method. The 
majority of labs applied the same method for muscle and kidney. Only one lab carried out an 
additional extraction for the kidney analysis using hexane. 
 
In this proficiency test three laboratories reported false negative results. These involved tylosin in 
muscle and tilmicosin in kidney. One of these labs also reported a false positive result: spiramycin in 
muscle. 
 
Table 9: Overview of the amount of satisfactory results for accuracy 
Matrix Compound No. 
laboratories 
that reported 
results 
No. of 
satisfactory 
results for 
accuracy 
No. of 
questionable 
results for 
accuracy 
No. of 
unsatisfactory 
results for 
accuracy 
Muscle Tylosin 10 8 2 0 
 Josamycin 8 5 1 2 
 Lincomycin 8 8 0 0 
 Tulathromycin 5 5 0 0 
Kidney Tylosin 10 7 3 0 
 Josamycin 7 5 1 1 
 Tilmicosin 6 6 0 0 
 
In all cases u > 0.3σp. This indicates that there is a severe variation among the laboratories. For several 
compounds the difference between the lowest and the highest reported value is a factor 5. As a result 
of this variation 6 of the 11 laboratories obtained questionable or unsatisfactory results.  
 
Based on the results of this proficiency study it is concluded that: 
• Although regulations for most macrolides are established before 2005, many laboratories do not 
have a validated and accreditated method for the analysis of all relevant macrolides.  
• For all compounds in both matrices the variation among the laboratories is severe. 
 
 
